Listen
Newsletters
Home
AI
World
Politics
Health
Crime & justice
Science & technology
Social issues
Sports
Money
Entertainment
Environment/energy
Military
Culture
Weather
Media
Home
Bias Split
Public Figures
Controversies
Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters
Sign Up!
Sign Up Now!
How our sliders work
About
Contact Us
Newsletter Archive
Privacy Policy
Testing
US genetic testing company 23andMe announced that it's laying off 40% of its staff, or about 200 employees, as well as shutting down its drug development business.
23andMe to Slash 40% of Staff
+2
DEC 1 2024
DEC 1 2024
Test Claims to Detect Prostate Cancer in 15 Minutes or Less
+3
OCT 1 2024
OCT 2024
Study: Glowing Dye Could Potentially be Used to Help Treat Prostate Cancer
+5
JUL 1 2024
JUL 2024
AI-Powered Blood Test May Predict Parkinson's Years in Advance
+3
JUL 1 2024
JUL 2024
Congress Passes Another Short-Term Funding Bill
+7
MAY 1 2024
MAY 2024
Show More